Albemarle (ALB) Research & Development (2009 - 2025)

Albemarle (ALB) has reported Research & Development for 17 consecutive years, with $12.4 million the latest figure, recorded in Q2 2025.

• For the quarter ending Q2 2025, Research & Development fell 40.09% year-over-year to $12.4 million; the trailing twelve-month figure through Jun 2025 stood at $69.0 million (down 21.76% YoY), and the FY2025 full-year result was $51.4 million, down 40.73% from the prior year.
• Research & Development declined to $12.4 million in Q2 2025 per ALB's latest filing, from $14.1 million in the prior quarter.
• Across five years, Research & Development topped out at $23.5 million in Q1 2024 and bottomed at $12.1 million in Q4 2021.
• Historically, Research & Development has averaged $18.1 million across 5 years, with a median of $19.2 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Research & Development jumped 66.22% in 2022, then tumbled 40.09% in 2025.
• Over 5 years, Research & Development stood at $12.1 million in 2021, then soared by 66.22% to $20.2 million in 2022, then increased by 12.9% to $22.8 million in 2023, then fell by 12.01% to $20.0 million in 2024, then sank by 37.85% to $12.4 million in 2025.
• According to Business Quant data, Research & Development over the past three periods registered $12.4 million, $14.1 million, and $20.0 million for Q2 2025, Q1 2025, and Q4 2024 respectively.